Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

April 30, 2007

Conditions
Bipolar I DisorderAlcohol Dependence
Interventions
DRUG

Quetiapine fumarate

DRUG

lithium

DRUG

divalproex

Trial Locations (38)

Unknown

Research Site, Cerritos

Research Site, San Diego

Research Site, New Haven

Research Site, Jacksonville

Research Site, Maitland

Research Site, Orlando

Research Site, Eagle

Research Site, Shreveport

Research Site, Glen Burnie

Research Site, Boston

Research Site, St Louis

Research Site, Moorestown

Research Site, Albuquerque

Research Site, New York

Research Site, Staten Island

Research Site, The Bronx

Research Site, Chapel Hill

Research Site, Research Triangle Park

Research Site, Cincinnati

Research Site, Cleveland

Research Site, Dayton

Research Site, Portland

Research Site, Media

Research Site, Philadelphia

Research Site, Pittsburgh

Research Site, Columbia

Research Site, Memphis

Research Site, Nashville

Research Site, Austin

Research Site, Dallas

Research Site, Houston

Research Site, San Antonio

Research Site, Wichita Falls

Research Site, Richmond

Research Site, Bellevue

Research Site, Kirkland

Research Site, Seattle

Research Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY